CHESTGuidelines & Topic CollectionsPulmonary Vascular Disease

Pulmonary Vascular Disease

Advertisement

Must-reads and more in the CHEST® journal portfolio

CHEST Journal image
JOURNAL CHEST®

Physical Activity Measured by Hip-Anchored Accelerometry in Pediatric Pulmonary Hypertension: Association With Disease Severity and Estimation of Minimal Important Differences

Treatment With Oral or Inhaled Treprostinil in Patients With Pulmonary Arterial Hypertension and Cardiovascular Comorbidities

CHEST® PULMONARY

Practice Patterns and Outcomes of Initial Anticoagulation Among Hospitalized Patients With Low- and Low-Intermediate-Risk Pulmonary Embolism

Potential Clinical Impact of Revised Pulmonary Hypertension Definitions at Moderate Altitude

EARN CME CREDIT

Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis

visual abstract
GRAPHICAL ABSTRACT

Do H2-Receptor Antagonists Improve Outcomes in Patients With PAH?

VIEW THE DOWNLOADABLE PDF

READ THE RELATED ARTICLE »

CHEST JOURNAL PORTFOLIO | Access even more pulmonary vascular disease research. READ THE JOURNALS »

GUIDELINES BY TOPIC | Review practice-changing recommendations for PVD.
ACCESS PULMONARY VASCULAR GUIDELINES »

On this page

RESOURCES

Clinician education resources

NEWS

News and notes

Advertisement

Join the Pulmonary Vascular and Cardiovascular Network

CHEST Networks are specialty-focused communities that provide forums for leadership, education, and advocacy. The Pulmonary Vascular and Cardiovascular Network focuses on the scientific knowledge and clinical practices in the areas of cardiovascular medicine and pulmonary vascular disease for health care providers.

LEARN MORE »

Pulmonary vascular disease news and notes

Follow the latest pulmonary vascular disease news

PULMONARY VASCULAR DISEASE SECTION

Shared Decision-Making in PAH: A Utopian Dream or an Achievable Goal?
Shared decision-making, a collaborative process that balances medical evidence with patient values, can be especially important in complex conditions like PAH.

CHEST PHYSICIAN®

Pooled Data Suggest Sotatercept as Novel Disease-Modifying Therapy for PAH
Aaron B. Waxman, MD, PhD, FCCP, said he believes the drug will become a first-line therapy option, but questions remain regarding when to initiate treatment.

CARDIOVASCULAR MEDICINE AND SURGERY SECTION

Turning the Tide in Right Ventricular Failure: The Role of Mechanical Support
As mechanical circulatory support technologies advance, understanding the unique features of right-sided devices is essential for optimal patient selection.

JOURNAL EDITORIAL

Beta-Blockers in PAH: Physiology Getting in Biology’s Way
While beta-blockers help in left-sided heart failure, they may be harmful in PAH. The current guidelines recommend against this use unless they are indicated for comorbidities.

Build your pulmonary vascular disease expertise

CHEST SEEK® Education

Written and peer reviewed by renowned experts in the critical care, pulmonary, and sleep medicine fields, the online CHEST SEEK Library and print publications include case-based questions and detailed rationales to stimulate and challenge your clinical thought process; help you prepare for certification or recertification exams; and allow you to obtain CME credit, MOC points, and CE hours.

CHEST SEEK LIBRARY

Access hundreds of critical care, pulmonary, and sleep medicine questions.

PURCHASE NOW »

Join the community

If you’re not already a CHEST member, become one today for access to additional resources, discounts on educational activities, and networking opportunities.

JOIN NOW »